Recently, a study showed that siRNA-mediated silencing of LAMB3 could enhance the sensitivity of head and neck squamous cell carcinoma cells to cisplatin (49), which may explain why PIGR can also increase the sensitivity of CRC cells to cisplatin. Here, PIGR is linked to head and neck squamous cell carcinoma.